OQROGet OQRO Pro
Politician trade (House)

Pfizer (PFE)Rep. James French Hill (AR02) disclosed a sale $100K–$250K

Rep. James French Hill (AR02) disclosed a sale of Pfizer in the $100K–$250K range.

$100,001–$250,000
Reported range · official band, not an exact amount
23 days
Disclosure lag
Traded
Dec 31, 2025
Disclosed
Jan 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 17, 2025Congress · 1 personMembers of Congress: 2 purchases
  2. Nov 4, 2025Company filing · Form 8-K · ResultsReported its results
  3. Nov 18, 2025CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
  4. Nov 26, 2025Government · Federal Register noticeForeign-Trade Zone (FTZ) 43; Authorization of Limited Production Activity; Pfizer, Inc.; (Pharmaceutical Intermediate Product); Kalamazoo, Michigan
  5. Dec 12, 2025Government · Federal Register noticePfizer Inc., U.S. Agent for King Pharmaceuticals LLC, et al.; Withdrawal of Approval of 20 Abbreviated New Drug Applications
  6. Dec 19, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
  7. Dec 31, 2025 · this disclosureCongressDisclosed sale of PFE — reported range $100,001 - $250,000

What came next

  1. Jan 2, 2026Government · Federal Register noticeRevocation of Two Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID-19; Availability
  2. Jan 23, 2026Federal contract · $22K obligatedDepartment of Defense awarded Pfizer: $22K obligated to date
  3. Jan 26, 2026Federal contract · $9K obligatedDepartment of Defense awarded Pfizer: $9K obligated to date
  4. Jan 29, 2026Federal contract · $3K obligatedDepartment of Defense awarded Pfizer: $2.8K obligated to date
  5. Feb 3, 2026Company filing · Form 8-K · ResultsReported its results
  6. Feb 9, 2026Government · Federal Register ruleAir Plan Approval; Connecticut; Revised Format for Materials Incorporated by Reference
  7. Feb 10, 2026CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
  8. Feb 18, 2026Federal contract · $8K obligatedDepartment of Defense awarded Pfizer: $8.2K obligated to date
  9. Feb 19, 2026Government · Federal Register noticeGranting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
  10. Feb 24, 2026FDAFDA drug approval: Braftovi
  11. Feb 24, 2026FDAFDA drug approval: Braftovi
  12. Feb 26, 2026Government · Federal Register noticeDetermination of Regulatory Review Period for Purposes of Patent Extension; ORLYNVAH
  13. Mar 6, 2026FDAFDA drug approval: Xeljanz
  14. Mar 6, 2026FDAFDA drug approval: Xeljanz XR
  15. Mar 9, 2026Government · Federal Register noticeAspen Global Inc. c/o Lachman Consultant Services, Inc., et al.; Withdrawal of Approval of 46 New Drug Applications
  16. Mar 13, 2026CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
  17. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  18. Apr 3, 2026Government · Federal Register noticeDetermination of Regulatory Review Period for Purposes of Patent Extension; HYMPAVZI
  19. Apr 8, 2026Federal contract · $15K obligatedDepartment of Defense awarded Pfizer: $15K obligated to date
  20. Apr 23, 2026Federal contract · $2K obligatedDepartment of Defense awarded Pfizer: $2.2K obligated to date
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Pfizer

For Pfizer, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 54 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.

Other recent filings by Rep. James French Hill (AR02)

The full history of Rep. James French Hill (AR02) is on the profile page.

How this filing works

Other disclosures at Pfizer

Everything OQRO holds on this company is on its PFE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data